Lyra Therapeutics Inc LYRA Valuation Ratios and Share Stats

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Lyra Therapeutics Inc (LYRA)
Lyra Therapeutics Inc (LYRA) Financials

Lyra Therapeutics Inc (LYRA)

0.3759

0.0133

( 3.67% )

Updated: 14:55:50

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End December 30 2023	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Return on Assets (%)	-47.549	-80.879	-46.198	-64.133	-67.071	-49.634
Return on Equity (%)	11.261	14.154	90.599	-79.981	-96.077	-73.666
Return on Invested Capital (%)	-63.259	-114.505	-55.559	-81.318	-100.64	-80.476
Operating Margin (%)	-484.646	N/A	N/A	-15267.719	-4054.659	-4019.32
Net Profit Margin (%)	-484.646	N/A	N/A	-15267.719	-4055.613	-4023.107
Book Value Per Share	136.935	31.861	5.76	2.638	2.537	1.701
Earnings Per Share	-35.465	-70.896	-1.711	-3.345	-1.737	-1.192
Cash Per Share	140.518	42.643	5.768	3.517	1.023	0.425
Working Capital Per Share	135.1	21.352	5.493	2.281	2.713	1.621
Operating Profit Per Share	7.318	N/A	N/A	0.022	0.043	0.03
EBIT Per Share	-35.465	-70.896	-1.711	-3.345	-1.736	-1.191
EBITDA Per Share	-35.465	-70.896	-1.711	-3.345	-1.736	-1.191
Free Cash Flow Per Share	-35.729	-70.096	-1.581	-3.162	-1.765	-1.178

Liquidity Ratios

Year End December 30 2023	2018	2019	2020	2021	2022	2023
Current Ratio	12.718	1.943	15.544	2.626	6.968	5.349
Quick Ratio	12.188	1.883	15.273	2.507	6.765	5.243
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	170k	230k	12.93M	13.01M	31.83M	N/A

Key Stats and Ratios

Year End December 30 2023	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Shares Outstanding	13.01M	31.83M	31.83M	31.83M	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	-135.867	N/A	N/A	N/A	-3961.22	N/A	N/A	N/A
Net Profit Margin (%)	-135.867	N/A	N/A	N/A	-3964.634	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	2.278	N/A	N/A	N/A	5.991	N/A	N/A	N/A
Quick Ratio	1.896	N/A	N/A	N/A	5.843	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	18.92M
Price to Earnings Ratio	-0.3
Price to Sales Ratio	12.16
Price to Cash Ratio	0.85
Price to Book Ratio	0.21
Dividend Yield	-

Share Statistics

Shares Outstanding	52.56M
Average Volume (1 week)	7.62M
Average Volume (1 Month)	7.63M
52 Week Change	-85.97%
52 Week High	6.79
52 Week Low	0.3477

More Ratios Coming Soon!

Lyra Therapeutics

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions